Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Long-Term Debt Issuances (2022 - 2024)

Historic Long-Term Debt Issuances for Pliant Therapeutics (PLRX) over the last 2 years, with Q4 2024 value amounting to $1000.0.

  • Pliant Therapeutics' Long-Term Debt Issuances changed N/A to $1000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $1000.0, marking a year-over-year decrease of 9999.5%. This contributed to the annual value of $19.9 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Pliant Therapeutics reported Long-Term Debt Issuances of $1000.0 as of Q4 2024.
  • Over the past 5 years, Pliant Therapeutics' Long-Term Debt Issuances peaked at $19.9 million during Q1 2024, and registered a low of -$150000.0 during Q4 2022.